AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

L'Oréal

M&A Activity Feb 25, 2011

1467_iss_2011-02-25_90818de6-cf19-4763-b1ff-587996ed0349.pdf

M&A Activity

Open in Viewer

Opens in native device viewer

This press release may not, directly or indirectly, be distributed or published in the United States, Australia, Japan, Canada, New Zealand, Hong Kong or South Africa. The offer is not being made to (and acceptances will not be accepted from) persons in those countries or elsewhere where their participation requires further documentation, filings or other measures in addition to those required by Swedish law.

Galderma declares its offer for Q-Med unconditional and will acquire all tendered shares

Please click on the following link to see the full press release:

http://bit.ly/gfSpRH

Lausanne, 25 February 2011

Galderma Pharma SA

The Board of Directors

Stockholm, 25 February 2011

Galderma Holding AB[1]

The Board of Directors

This information was submitted for publication on 25 February 2011 at 3:30 pm (CET).

For additional information contact:

Peter Nicholson, Galderma

+33 676 22 71 18

Anders Fogel, Brunswick Group

+46 8 410 32 180

[1] A newly formed company wholly owned by Galderma S.A., under change of name from Goldcup 6138 AB to Galderma Holding AB.

Talk to a Data Expert

Have a question? We'll get back to you promptly.